Bids Are Invited For Acquisition Of Group 1B And Group 2 Medicines - Case

Tender Detail

105456067
DE0352/2025
Self-Funded
Bids Are Invited For Acquisition Of Group 1B And Group 2 Medicines - Case
NCB
South America
BRIC,G20
02-12-2025

Work Detail

Acitretin - Concentration/Dosage 10 Mg, Pharmaceutical Form Capsule, Oral Route Of Administration, Atorvastatin Calcium - Concentration/Dosage 80 Mg, Pharmaceutical Form Coated Tablet, Benzathine Benzylpenicillin - Concentration/Dosage 1,200,000 Iu, Pharmaceutical Form Powder For Injectable Suspension, Form Presentation Vial-Ampule, ., Bosentan - Concentration/Dosage 125 Mg, Bosentan - Concentration/Dosage 62.5 Mg, 11/27/2025 - 11:11:19, 11/27/2025 - 11:12:01, 11/27/2025 - 11:12:02, Cyclophosphamide - Concentration/Dosage 50 Mg, Tablet Pharmaceutical Form, Blister Or Strip Presentation Form, Clobetasol, Propionate - Concentration/Dosage 0.5 Mg/G, Cream Pharmaceutical Form, Tube Presentation Form, Topical Administration Route, Mesalazine - Concentration/Dosage 250 Mg, Pharmaceutical Form Suppository, Via Rectal Administration, Pamidronate Disodium - Concentration/Dosage 60 Mg + Diluent, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Vial-Ampule 10Ml, Intravenous Administration Route, Penicillamine - Concentration/Dosage 250 Mg, Formoterol, Fumarate - Concentration/Dosage 12 Mcg, Presentation Form Capsules + Inhaler, Inhalation Route Of Administration, Lamotrigine - Concentration/Dosage 25 Mg, Oral Administration Route, Lamotrigine - Concentration/Dosage 50 Mg, Loperamide, Hydrochloride - Concentration/Dosage 2 Mg, Mesalazine - Concentration/Dosage 400 Mg, Zinc Oxide + Retinol + Cholecalciferol - Concentration/Dosage (150 Mg +5,000 Iu + 900 Iu)/G Respectively, Pharmaceutical Form Ointment, Pancreatin - Concentration/Dosage 25,000 Iu, Ferric Hydroxide, Saccharate - Concentration/Dosage 20 Mg/Ml 5Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form, Intravenous Administration Route, Sacubitril/Valsartan - Sacubitril Valtarsana Sodica Hydrada 50 Mg, In Coated Tablet, Packed In Blister Or Strip As Specified In The Product Description. The Packaging Must Externally Contain The Identification Data, Batch, Manufacturing And Expiration Dates.

Key Value

Tender Value
40,46,965 - BRL

Attachment

FileName File Description
Global Tender Document 1d5307eb-b598-46d5-b77a-c10349b2a052.html
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail